Cite

HARVARD Citation

    Yap, S. et al. (2018). Immediate thrombocytopenia at time of alemtuzumab infusion for multiple sclerosis – Not always self-limiting, fully reversible or predictable. Multiple sclerosis. pp. 552-553. [Online]. 
  
Back to record